Principia Biopharma Inc. 4/A SEC Filings

Filed On	Filing
17 Jun 2020	Form 4/A: Wolff Stefani, Chief Development Officer Sold 5,504 shares ($254K)
17 Jun 2020	Form 4/A: Wolff Stefani, Chief Development Officer Sold 5,505 shares ($272K)
04 Sep 2019	Form 4/A: Tomasello Shawn, Director Granted 20,475 Director Stock Option (right to buy)

Comments